Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia

Cancer Res. 1971 Feb;31(2):84-90.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Bone Marrow Diseases / chemically induced
  • Child
  • Child, Preschool
  • Drug Tolerance
  • Heart Diseases / chemically induced
  • Humans
  • Infant
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / mortality
  • Leukopenia / chemically induced
  • Thrombocytopenia / chemically induced

Substances

  • Antibiotics, Antineoplastic